10,645 Shares in Semler Scientific, Inc. (NASDAQ:SMLR) Acquired by Verition Fund Management LLC

Verition Fund Management LLC purchased a new stake in Semler Scientific, Inc. (NASDAQ:SMLR) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 10,645 shares of the company’s stock, valued at approximately $251,000. Verition Fund Management LLC owned approximately 0.15% of Semler Scientific as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Cerity Partners LLC raised its holdings in shares of Semler Scientific by 91.5% during the third quarter. Cerity Partners LLC now owns 1,345,586 shares of the company’s stock worth $31,689,000 after acquiring an additional 642,982 shares during the period. Shariaportfolio Inc. bought a new position in Semler Scientific during the 3rd quarter worth about $3,618,000. AQR Capital Management LLC raised its stake in shares of Semler Scientific by 150.1% in the 2nd quarter. AQR Capital Management LLC now owns 140,498 shares of the company’s stock valued at $4,833,000 after purchasing an additional 84,314 shares during the period. Crawford Fund Management LLC bought a new stake in shares of Semler Scientific in the third quarter valued at about $883,000. Finally, Dimensional Fund Advisors LP boosted its position in shares of Semler Scientific by 18.3% during the second quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company’s stock worth $4,341,000 after buying an additional 19,552 shares during the period. Institutional investors and hedge funds own 49.37% of the company’s stock.

Semler Scientific Stock Performance

NASDAQ:SMLR opened at $67.17 on Friday. The company has a market cap of $556.77 million, a PE ratio of 32.77 and a beta of 1.18. The stock has a 50-day simple moving average of $43.82 and a 200 day simple moving average of $34.79. Semler Scientific, Inc. has a 52-week low of $20.88 and a 52-week high of $79.45.

Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.35. The company had revenue of $13.51 million for the quarter. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.